Prednisolone Improves IVF Outcomes in Men With Anti-sperm Antibodies
Launched by BARZ IVF CENTER FOR INFERTILITY TREATMENT AND EMBRYO RESEARCH · Oct 14, 2016
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
This prospective study was conducted at the Barz IVF Center for Infertility Treatment and Embryo Research, Erbil, Kurdistan Region, Iraq and the Baghdad University Teaching Hospital of the College of Medicine, University of Baghdad, Baghdad, Iraq between October 2014 and May 2016. In all cases, the wife's ova were inseminated with the husband's semen samples. Identified men with positive ASAs were randomly assigned for treatment with or without prednisolone for three cycles. Infertile men were treated with prednisolone tablet, po, for 21 days of their wife's menstrual cycles. Briefly, the p...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Female partners had complete or partial tubal patency
- • Male partners with anti-sperm antibodies
- • Male partners with sperm count \> 35 million/ml.
- Exclusion Criteria:
- • Female partners with polycystic ovary
- • Female partners with endometriosis
- • Female partners with abnormal profile of reproductive hormones
- • Female partners with abnormal profile of thyroid hormones
- • Male partners with seminal fluid infections (e.g. leukospermia)
- • Male partners with abnormal profile of reproductive hormones
- • Male partners with abnormal profile of thyroid hormones
About Barz Ivf Center For Infertility Treatment And Embryo Research
Barz IVF Center for Infertility Treatment and Embryo Research is a leading clinical trial sponsor dedicated to advancing reproductive health through innovative research and cutting-edge technologies. Specializing in infertility treatment, the center is committed to providing comprehensive care and support for individuals and couples seeking to conceive. By conducting rigorous clinical trials, Barz IVF Center aims to enhance treatment efficacy, improve patient outcomes, and contribute to the scientific understanding of embryonic development and reproductive medicine. With a patient-centered approach and a focus on ethical research practices, the center strives to make significant contributions to the field of infertility treatment and embryo research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Saeeda A. Muhsen, DVM, PhD
Principal Investigator
Barz IVF Center for Infertility Treatment and Embryo Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials